School of Medicine, Cardiff University, Cardiff, UK.
Department of Cardiothoracic Surgery, University Hospital of Wales, Cardiff, UK.
Int Wound J. 2016 Dec;13(6):1142-1149. doi: 10.1111/iwj.12430. Epub 2015 Feb 26.
Postoperative deep sternal wound infection (DSWI) is a serious complication in cardiac surgery (1-5% of patients) with high mortality and morbidity rates. Vacuum-assisted closure (VAC) therapy has shown promising results in terms of wound healing process, postoperative hospital length of stay and lower in-hospital costs. The aim of our retrospective study is to report the outcome of patients with DSWI treated with VAC therapy and to assess the effect of contributory risk factors. Data of 52 patients who have been treated with VAC therapy in a single institution (study period: September 2003-March 2012) were collected electronically through PAtient Tracking System PATS and statistically analysed using SPSS version 20. Of the 52 patients (35 M: 17 F), 88·5% (n = 46) were solely treated with VAC therapy and 11·5% (n = 6) had additional plastic surgical intervention. Follow-up was complete (mean 33·8 months) with an overall mortality rate of 26·9% (n = 14) of whom 50% (n = 7) died in hospital. No death was related to VAC complications. Patient outcomes were affected by pre-operative, intra-operative and postoperative risk factors. Logistic EUROscore, postoperative hospital length of stay, advanced age, chronic obstructive pulmonary disease (COPD) and long-term corticosteroid treatment appear to be significant contributing factors in the long-term survival of patients treated with VAC therapy.
术后胸骨深部伤口感染(DSWI)是心脏手术的一种严重并发症(占患者的 1-5%),具有较高的死亡率和发病率。负压辅助闭合(VAC)治疗在伤口愈合过程、术后住院时间和降低住院费用方面显示出良好的效果。我们的回顾性研究旨在报告接受 VAC 治疗的 DSWI 患者的结果,并评估相关风险因素的影响。通过 PAtient Tracking System PATS 电子收集了在一家机构接受 VAC 治疗的 52 例患者的数据(研究期间:2003 年 9 月至 2012 年 3 月),并使用 SPSS 版本 20 进行了统计学分析。52 例患者中(35 例男性:17 例女性),88.5%(n=46)仅接受 VAC 治疗,11.5%(n=6)接受了额外的整形手术干预。随访完整(平均 33.8 个月),总死亡率为 26.9%(n=14),其中 50%(n=7)在医院死亡。没有死亡与 VAC 并发症有关。患者的预后受到术前、术中及术后风险因素的影响。逻辑 EUROscore、术后住院时间、高龄、慢性阻塞性肺疾病(COPD)和长期皮质类固醇治疗似乎是接受 VAC 治疗的患者长期生存的重要影响因素。